title: Re: Yamamoto et al.: One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy (Ophthalmology 2015;122:1866-72).
authors.affiliation: Department of Ophthalmology, Kim's Eye Hospital, Konyang University College of Medicine, Seoul, South Korea. Electronic address: kimoph@gmail.com.
authors.forename: Jae Hui
authors.initials: JH
authors.lastname: Kim
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011127:Polyps / Q000188:drug therapy*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; D040262:Receptors, Vascular Endothelial Growth Factor